// App-Quantinova.ai

P608 : Systematic review: The impact and importance of body composition in Inflammatory Bowel Disease

Researchers

Presenter

  • Ding, N

Principal Investigators

  • Tassone, D

  • Al Bakir, I

  • Wu, K

  • Connell, W

  • Thompson, A

  • Malietzis, G

  • Lung, P

  • Singh, S

  • Choi, C.H

  • Gabe, S

  • Jenkins, J

  • Hart, A

Medical Centers

  • St Vincents Hospital, Gastroenterology, Fitzroy, Australia

  • St Mark's Hospital and Academic Institute, Inflammatory Bowel Disease, Harrow, United Kingdom

  • Imperial College London, Department of Surgery and Cancer, London, United Kingdom

  • University of California San Diego, Gastroenterology, La Jolla, CA, United States

Locations

  • Australia

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Gastroenterology (GU)

  • Genetic Disorder

Disease

  • Inflammatory bowel disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A